Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. Could a new gene-editing technology permanently cure Duchenne muscular dystrophy?
  2. GlobalData reports strong growth in monoclonal antibodies during clinical trials from 2007-2016
  3. GSK’s Shingrix set to disrupt the herpes zoster vaccine marketplace
  4. Failure of first lampalizumab Phase III study could delay availability
  5. Lack of sleep increases risk of Alzheimer’s disease

Latest Content

Dynamic Light Scattering – Common Terms Defined

There are a number of sources of information that give a mathematical description of the terms used in light scattering. However, these will not usually give assistance in understanding their practical application.

Benefits of Trehalose

Products such as monoclonal antibodies (mAb), fusion proteins, peptides, vaccines, antibody drug conjugulates (ADC) and stem cells benefit from the stabilising effects of Trehalose.

Carbohydrates Could be Crucial to an Effective Malaria Vaccine

Despite the need for a vaccine to prevent malaria, particularly in infants and young children, R&D efforts to date have been plagued by a lack of protective efficacy, particularly related to the duration of protection. Even the most advanced vaccine candidate, GlaxoSmithKline’s (GSK’s) subunit vaccine Mosquirix (RTS,S/AS01), possesses clear drawbacks in its ability to effectively protect those who are most vulnerable to severe infections.

GSK’s Shingrix set to disrupt the herpes zoster vaccine marketplace

On September 13, GlaxoSmithKline (GSK) announced that the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend the approval of its investigational vaccine, Shingrix (zoster vaccine, recombinant [adjuvanted]), for the prevention of herpes zoster (HZ) in adults ≥50 years of age.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top